Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 95 record(s)

Req # A-2020-001407

Adverse Drug Reactions (ADRs) for Fosamax. Report numbers: E2B_01498392, E2B_01497348, E2B_01550413, E2B_01559129, E2B_01560554, E2B_01560565, E2B_01563727, E2B_01563841, E2B_01565657, E2B_01566184, E2B_01567431, E2B_01568489, E2B_01575803, E2B_01575807, E2B_01577804, E2B_01577891.

Organization: Health Canada

420 page(s)
October 2021

Req # A-2021-000282

Adverse Drug Reaction (ADR) for PLAQUENIL. Report number: E2B_03706156.

Organization: Health Canada

32 page(s)
October 2021

Req # A-2021-000353

Adverse Drug Reaction (ADR) for ROSUVASTATIN CALCIUM. Report number: E2B_03467451.

Organization: Health Canada

22 page(s)
October 2021

Req # A-2021-000372

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03820452.

Organization: Health Canada

37 page(s)
October 2021

Req # A-2021-000374

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03809058.

Organization: Health Canada

10 page(s)
October 2021

Req # A-2021-000633

Adverse Drug Reactions (ADRs) for METFORMIN HYDROCHLORIDE. Report numbers: E2B_03482740, E2B_02691752.

Organization: Health Canada

53 page(s)
October 2021

Req # A-2021-000660

Adverse Drug Reaction (ADR) for PREDNISONE. Report number: E2B_03501659.

Organization: Health Canada

14 page(s)
October 2021

Req # A-2021-000700

Adverse Drug Reactions (ADRs). Report numbers: E2B_03496486, E2B_03092641.

Organization: Health Canada

22 page(s)
October 2021

Req # A-2021-000739

Adverse Drug Reaction (ADR) for HYDROCHLOROTHIAZIDE. Report number: E2B_03406806.

Organization: Health Canada

10 page(s)
October 2021

Req # A-2021-000793

Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: E2B_03379657, E2B_03456958, E2B_03508675.

Organization: Health Canada

73 page(s)
October 2021
Date modified: